ArticleCureus2026
Coexisting Graves' Disease and Papillary Thyroid Carcinoma: The Importance of Nodule Surveillance in Autoimmune Hyperthyroidism.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Graves' disease (GD) is an autoimmune disorder characterized by hyperthyroidism and is commonly associated with diffuse thyroid enlargement. The coexistence of thyroid nodules in GD presents diagnostic and management challenges, particularly when malignancy is a concern. We report a 44-year-old woman with asymptomatic biochemical hyperthyroidism detected during routine screening. Initial ultrasound revealed a subcentimeter right thyroid nodule (TI-RADS TR4), for which surveillance was recommended. Follow-up imaging demonstrated interval growth, prompting fine-needle aspiration that was suspicious for papillary thyroid carcinoma (PTC) (Bethesda V). Molecular analysis revealed a rare BRAF mutation with an estimated ~70% probability of malignancy. The patient underwent total thyroidectomy with central neck dissection, confirming a 1.1 cm classic PTC with microscopic nodal metastasis (pT1bN1a). She recovered uneventfully and remains under endocrinology follow-up. This case underscores the importance of structured ultrasound surveillance in patients with GD, even in the absence of clinical symptoms. A multimodal diagnostic approach incorporating imaging, cytology, and molecular analysis can facilitate early detection and informed risk stratification, supporting timely and appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.